Division of Human Imaging

Projects

The goal of the Human Imaging Division is to elucidate the multilevel pathogenesis of neurodegenerative diseases based on brain imaging. We are conducting cutting-edge multimodal brain imaging research in close collaboration with the Department of Radiology, aiming at the development of ultra-early diagnosis methods and innovative biomarkers. We also collect brain images and biological samples, and use AI and mathematical models to assess the relationship between brain imaging findings and multi-level pathophysiological conditions to discover new therapeutic targets.

Members

Watanabe Hirohisa

Watanabe Hirohisa Neurology Professor

We have been building a large-scale registry of high-quality clinical data, brain images, and biological samples for neurodegenerative diseases, and using this registry to conduct network analysis, mathematical modeling, and consortium-based studies of molecular pathology.

Mizuki Ito

Mizuki Ito Clinical Professor of Neurology

Our research focuses on the early diagnosis and assessment of neurodegenerative diseases. Using MRI and nuclear medicine imaging, we develop biomarkers to monitor disease progression.

Yasuaki Mizutani

Yasuaki Mizutani Associate Professor, Department of Neurology

I am promoting research on biomarkers involved in the pathogenesis of neurodegenerative diseases through the high-quality storage of biological samples and new methods of measurement/analysis in cooperation with investigators in our university and other institutions, and I am engaged in the establishment/management of a registry system for patients with neurodegenerative diseases and healthy adults.

Sayuri Shima

Sayuri Shima Senior Assistant Professor, Department of Neurology

I assist in the operation of a registry system for patients with neurodegenerative disease and healthy aging subjects. I also conduct research on a 3D VR navigation system for the detection of entorhinal cortex lesions, considered the earliest detectable pathological change in Alzheimer's disease, to improve the early diagnosis of AD.

Ryunosuke Nagao

Ryunosuke Nagao Assistant Professor, Department of Neurology

I am analyzing clinical data on neurodegenerative diseases, represented by multiple system atrophy, and brain function images to clarify the pathogenesis of these diseases for early diagnosis/therapeutic intervention and the development of specific biomarkers.

Toshiki Maeda

Toshiki Maeda Assistant Professor, Department of Neurology

I am promoting research to clarify the pathogenesis of Parkinson’s disease using procedures, such as cerebral blood flow SPECT, adopting the latest statistical analysis methods. Results regarding the etiology of a reduction in primary visual cortex blood flow in the presence of this disease have been obtained.

Atsuhiro Higashi

Atsuhiro Higashi Assistant Professor, Department of Neurology

My work focuses on understanding the pathophysiology of Parkinson's disease through the analysis of clinical data, plasma metabolomics, and body composition, combined with the collection of healthy subject data.

Kazutaka Hayashi

Kazutaka Hayashi Assistant Professor, Department of Neurology

I am investigating the clinical and image characteristics of diseases, including posterior spinal artery syndrome, useful for diagnosis and treatment by comparing/analyzing MRI findings of the spinal cord and their serial changes.

Reiko Ohdake

Reiko Ohdake Speech-Language Pathologist, Department of Neurology

I concentrate on understanding the pathophysiology of neurodegenerative diseases, particularly Parkinson's disease, by studying temporal changes in higher brain functions and developing early diagnostic methods using visual, auditory, and vocal indicators.

Main publications

  1. Kawabata K, Bagarinao E, Seppi K, Poewe W. Longitudinal brain changes in Parkinson's disease with severe olfactory deficit. Parkinsonism Relat Disord.
    2024 May:122:106072. doi: 10.1016/j.parkreldis.2024.106072. 
  2. Kawabata K, Djamshidian A, Bagarinao E, Weintraub D, Seppi K, Poewe W. Cognitive dysfunction in de novo Parkinson disease: Remitting vs. progressive cognitive impairment. Parkinsonism Relat Disord.
    2024 Mar:120:105984.doi: 10.1016/j.parkreldis.2023.105984.
  3. Nagao R, Mizutani Y, Shima S, Ueda A, Ito M, Yoshimoto J, Watanabe H. Correlations between serotonin impairments and clinical indices in multiple system atrophy. Eur J Neurol. 2023 Dec 12. doi: 10.1111/ene.16158.
  4. Mizutani Y, Ohdake R, Tatebe H, Higashi A, Shima S, Ueda A, Ito M, Tokuda T, Watanabe H. Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease. J Neurol. 2023 Nov;270(11):5461-5474. doi: 10.1007/s00415-023-11875-z.
  5. Mizutani Y, Nawashiro K, Ohdake R, Tatebe H, Shima S, Ueda A, Yoshimoto J, Ito M, Tokuda T, Mutoh T, Watanabe H. Enzymatic properties and clinical associations of serum alpha-galactosidase A in Parkinson's disease. Ann Clin Transl Neurol. 2023 Sep;10(9):1662-1672. doi: 10.1002/acn3.51856.

Information

Division of Human Imaging(Neurology, School of Medicine)

【Address】
Fujita Health University, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan
【Contact】
E-mail:sinkeinaika(at)yahoo.co.jp
※ Please replace “(at)” with “@”.